Literature DB >> 15142994

Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome.

C Kailasam1, S D Keay, P Wilson, W C L Ford, J M Jenkins.   

Abstract

BACKGROUND: Poor ovarian response limits IVF success but assessing interventions is difficult because of the wide variation in definition. This study attempts to derive objective definitions of poor response.
METHODS: A retrospective study of a consecutive series of 1190 patients aged <40 years undergoing their first IVF/ICSI cycle was undertaken. Factors adversely affecting implantation, including advanced female age, were excluded. Clinical outcome in cycles reaching oocyte retrieval (n = 1036) were evaluated with respect to gonadotrophin dose used and oocyte number. Cancelled cycles (n = 154) were analysed in relation to the stimulation dose at cancellation and outcome of their subsequent cycle.
RESULTS: Cycle cancellation for patients on >/=300 IU FSH/day compared to those on a lower dose was associated with a significantly worse outcome in the subsequent cycle. If <3000 IU FSH/cycle were administered, clinical pregnancy rates remained favourable if <4 eggs were recovered (29 versus 33% for >/=5 eggs). By contrast, if >/=3000 IU FSH was required, the pregnancy rate was 25% if >/=5 eggs were recovered but declined to 7% if <4 were obtained.
CONCLUSIONS: Definitions of poor response should include the degree of ovarian stimulation used. A low oocyte number is only detrimental if the cumulative dose is >3000 IU FSH. Cancellation at >/=300 IU FSH/day is associated with a significantly worse prognosis and could define poor response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142994     DOI: 10.1093/humrep/deh273

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

1.  Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.

Authors:  C Kailasam; V Akande; U D Gordon
Journal:  J Assist Reprod Genet       Date:  2005-03       Impact factor: 3.412

2.  Follicular sensitivity index (FSI): a novel tool to predict clinical pregnancy rate in IVF/ICSI cycles.

Authors:  AbdelGany M A Hassan; Mohamed M M Kotb; Ahmed M A AwadAllah; Nesreen A A Shehata; Amr Wahba
Journal:  J Assist Reprod Genet       Date:  2017-07-03       Impact factor: 3.412

3.  Are poor responders patients at higher risk for producing aneuploid embryos in vitro?

Authors:  Amanda Souza Setti; Daniela Paes de Almeida Ferreira Braga; Rita de Cássia Savio Figueira; Matheus de Castro Azevedo; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2010-11-26       Impact factor: 3.412

4.  Comparison of two ovarian stimulation protocols among women with poor response: A randomized clinical trial.

Authors:  Minoodokht Bavarsadkarimi; Sirous Omidi; Farinaz Shahmoradi; Zahra Heidar; Sahar Mirzaei
Journal:  Eur J Transl Myol       Date:  2022-07-06

5.  The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples.

Authors:  X M Zhen; J Qiao; R Li; L N Wang; P Liu
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

6.  Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization.

Authors:  Ruma Satwik; Mohinder Kochhar; Shweta M Gupta; Abha Majumdar
Journal:  J Hum Reprod Sci       Date:  2012-05

7.  Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.

Authors:  Francesca Caprio; Maria Diletta D'Eufemia; Carlo Trotta; Maria Rosaria Campitiello; Raffaele Ianniello; Daniela Mele; Nicola Colacurci
Journal:  J Ovarian Res       Date:  2015-06-12       Impact factor: 4.234

Review 8.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

9.  Prediction and diagnosis of poor ovarian response: the dilemma.

Authors:  Ahmed Badawy; Alaa Wageah; Mohamed El Gharib; Ezz Eldin Osman
Journal:  J Reprod Infertil       Date:  2011-10

Review 10.  Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.

Authors:  Philippe Lehert; Efstratios M Kolibianakis; Christos A Venetis; Joan Schertz; Helen Saunders; Pablo Arriagada; Samuel Copt; Basil Tarlatzis
Journal:  Reprod Biol Endocrinol       Date:  2014-02-20       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.